JOINT FILING AGREEMENTJoint Filing Agreement • September 21st, 2021 • Point72 Asset Management, L.P. • Pharmaceutical preparations
Contract Type FiledSeptember 21st, 2021 Company IndustryThe undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.
JOINT FILING AGREEMENTJoint Filing Agreement • September 7th, 2021 • Point72 Asset Management, L.P. • Pharmaceutical preparations
Contract Type FiledSeptember 7th, 2021 Company IndustryThe undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.
JOINT FILING AGREEMENTJoint Filing Agreement • March 24th, 2021 • Point72 Asset Management, L.P. • Pharmaceutical preparations
Contract Type FiledMarch 24th, 2021 Company IndustryThe undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.